Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.

Shaffer BC, Al Malki MM, Jimenez AMJ, Stanek J, Bo-Subait S, Logan BR, Kou J, Leckrone E, Stefanski HE, Spellman SR, Malmberg C, Askar M, Cusatis R, Modi D, Khimani F, Hamadani M, Maiers M, Cook R, Ballen K, Bolaños-Meade J, Rao U, Milner J, Abboud R, Jamieson K, Carrum G, Dholaria B, Hogan WJ, Reshef R, Kosuri S, Loren A, Larkin K, Arai S, Qayed M, Choi SW, Broglie L, Auletta JJ, Shaw BE, Devine SM, Gooptu M

Open source

DOI
10.1002/ajh.70489
Published
2026 Aug 31
Container
American journal of hematology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ajh.70489,
  title = {Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.},
  author = {Shaffer BC and Al Malki MM and Jimenez AMJ and Stanek J and Bo-Subait S and Logan BR and Kou J and Leckrone E and Stefanski HE and Spellman SR and Malmberg C and Askar M and Cusatis R and Modi D and Khimani F and Hamadani M and Maiers M and Cook R and Ballen K and Bolaños-Meade J and Rao U and Milner J and Abboud R and Jamieson K and Carrum G and Dholaria B and Hogan WJ and Reshef R and Kosuri S and Loren A and Larkin K and Arai S and Qayed M and Choi SW and Broglie L and Auletta JJ and Shaw BE and Devine SM and Gooptu M},
  year = {2026},
  journal = {American journal of hematology},
  doi = {10.1002/ajh.70489},
  url = {https://doi.org/10.1002/ajh.70489}
}

RIS

TY  - JOUR
TI  - Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.
AU  - Shaffer BC
AU  - Al Malki MM
AU  - Jimenez AMJ
AU  - Stanek J
AU  - Bo-Subait S
AU  - Logan BR
AU  - Kou J
AU  - Leckrone E
AU  - Stefanski HE
AU  - Spellman SR
AU  - Malmberg C
AU  - Askar M
AU  - Cusatis R
AU  - Modi D
AU  - Khimani F
AU  - Hamadani M
AU  - Maiers M
AU  - Cook R
AU  - Ballen K
AU  - Bolaños-Meade J
AU  - Rao U
AU  - Milner J
AU  - Abboud R
AU  - Jamieson K
AU  - Carrum G
AU  - Dholaria B
AU  - Hogan WJ
AU  - Reshef R
AU  - Kosuri S
AU  - Loren A
AU  - Larkin K
AU  - Arai S
AU  - Qayed M
AU  - Choi SW
AU  - Broglie L
AU  - Auletta JJ
AU  - Shaw BE
AU  - Devine SM
AU  - Gooptu M
PY  - 2026
JO  - American journal of hematology
DO  - 10.1002/ajh.70489
UR  - https://doi.org/10.1002/ajh.70489
ER  - 

APA

BC, S., MM, A. M., AMJ, J., J, S., S, B., BR, L., J, K., E, L., HE, S., SR, S., C, M., M, A., R, C., D, M., F, K., M, H., M, M., R, C., K, B., J, B., U, R., J, M., R, A., K, J., G, C., B, D., WJ, H., R, R., S, K., A, L., K, L., S, A., M, Q., SW, C., L, B., JJ, A., BE, S., SM, D., & M, G. (2026). Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.. American journal of hematology. https://doi.org/10.1002/ajh.70489

Source records